530161 GARODCH

Garodia Chemicals Share Price

₹5.44 +0.25 (4.82%)

18 Nov, 2024 23:05

SIP TrendupStart SIP in GARODCH

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 15.25%
  • Over 3 Month -11.11%
  • Over 6 Month -33.58%
  • Over 1 Year -36.3%
SIP Lightning

Smart Investing Starts Here Start SIP with Garodia Chemicals for Steady Growth!

Invest Now

Garodia Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Garodia Chemicals Financials

Garodia Chemicals Technicals

EMA & SMA

Current Price
₹5.44
+ 0.25 (4.82%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹5.74
  • 50 Day
  • ₹6.58
  • 100 Day
  • ₹7.54
  • 200 Day
  • ₹9.47

Resistance and Support

5.44 Pivot Speed
  • R3 5.44
  • R2 5.44
  • R1 5.44
  • S1 5.44
  • S2 5.44
  • S3 5.44

What's your outlook on Garodia Chemicals?

You can only vote for once

Garodia Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-03 Quarterly Results

Garodia Chemicals F&O

Garodia Chemicals Shareholding Pattern

No data available.

About Garodia Chemicals

  • NSE Symbol
  • GARODCH
  • BSE Symbol
  • 530161
  • ISIN
  • INE236P01010

Similar Stocks to Garodia Chemicals

Garodia Chemicals FAQs

Garodia Chemicals share price is ₹5 As on 18 November, 2024 | 22:51

The Market Cap of Garodia Chemicals is ₹3.6 Cr As on 18 November, 2024 | 22:51

The P/E ratio of Garodia Chemicals is -34.6 As on 18 November, 2024 | 22:51

The PB ratio of Garodia Chemicals is -0.8 As on 18 November, 2024 | 22:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23